Risk Management

What physicians need to know about AI governance, safety, and responsible use in patient care.

What physicians need to know about AI governance, safety, and responsible use in patient care.

Semaglutide faces renewed legal battles as Novo Nordisk targets compounding pharmacies for trademark infringement and false advertising after FDA shortage removal.

A physician and health care attorney breaks down the American Law Institute’s recent restatement of the law of medical malpractice.

Nearly half of health care workers say they’re likely to leave their job within a year, citing safety concerns.

The possibility of a lawsuit or other liability damaging your practice and finances is very real.

Practical recommendations to consider in advance of exploring a potential sale or partnership transaction

Health care practices need to navigate real estate challenges and focus on strategic location decisions and data-driven insights to ensure future growth and patient care efficiency.

From ghost patients and fake genetic tests to DME laundering rings and opioid pill mills, the DOJ’s 2025 health care fraud crackdown paints a sobering picture of a system under attack — and a federal response gaining traction.

As workplace violence rises, health care facilities must shift from retrofitted tech to frontline-first safety solutions

Explore the essentials of forming a medical practice partnership, including operating agreements, income distribution, and buy-in/buy-out strategies before signing a contract.

Medical malpractice insurance needs an update

A recent district court case shows an LLC might not be enough

The secrets of evaluation and management coding success.

Occurrence, claims-made and tail insurance explained.

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?

GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?